Per Jeppesen, serves as Director, Drug Product Development, CMC at Hemab. He has more than 25 years of experience in the biotechnology and medical device industry across early- and late-stage process, formulation, and analytical development. Prior to joining Hemab, he worked at Novo Nordisk, firstly with formulation development of Drug Product as scientist and Project Manager, but in the last 15 years Per has been heading up departments in CMC, QA, and QC in Novo Nordisk. Per is originally educated as Chemical Engineer (BSc) from the Technical University of Denmark.